Faghihi, T., Jahed, A., Mahmoudi-Gharaei, J., Sharifi, V., Akhondzadeh, S., & Ghaeli, P. (2012). Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: A randomized double-blind placebo-controlled trial. BioMed Central.
শিকাগো স্টাইলে সাইটেশনFaghihi, Toktam, Adel Jahed, Javad Mahmoudi-Gharaei, Vandad Sharifi, Shahin Akhondzadeh, এবং Padideh Ghaeli. Role of Omega-3 Fatty Acids in Preventing Metabolic Disturbances in Patients On Olanzapine Plus Either Sodium Valproate or Lithium: A Randomized Double-blind Placebo-controlled Trial. BioMed Central, 2012.
এমএলএ সাইটেশনFaghihi, Toktam, et al. Role of Omega-3 Fatty Acids in Preventing Metabolic Disturbances in Patients On Olanzapine Plus Either Sodium Valproate or Lithium: A Randomized Double-blind Placebo-controlled Trial. BioMed Central, 2012.